Brancaccio V, Iannaccone L, Margaglione M, Guardascione M A, Amitrano L
Coagulation Unit, Cardarellí Hospital, Naples, Italy.
Clin Lab Haematol. 2002 Feb;24(1):61-3. doi: 10.1046/j.1365-2257.2002.00196.x.
Myeloproliferative disorders are the main cause of Budd-Chiari syndrome in western countries. Inherited or acquired thrombophilic factors have also been implicated. A novel mutation of the prothrombin gene (G-->A20210) has only been described in a few cases of Budd-Chiari syndrome so far. Venous thrombosis is often the result of multiple concomitant thrombophilic factors. We report the case of a patient with essential thrombocythemia and Budd-Chiari syndrome in which heterozygosity for both factor V Leiden and the mutation G20210A of the prothrombin gene were identified.
骨髓增殖性疾病是西方国家布加综合征的主要病因。遗传或获得性血栓形成倾向因素也与之相关。凝血酶原基因的一种新突变(G→A20210)迄今为止仅在少数布加综合征病例中被描述过。静脉血栓形成往往是多种并存的血栓形成倾向因素共同作用的结果。我们报告了一例原发性血小板增多症合并布加综合征的患者,该患者同时检测到凝血因子V Leiden杂合子和凝血酶原基因突变G20210A。